The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV of formula I, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are associated with proteins that are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity.
本发明涉及公式I的治疗活性和选择性
抑制剂DPP-IV的药物,包括这些化合物的制药组合物以及使用这些化合物制备治疗与
DPP-IV失活蛋白相关的疾病(例如2型糖尿病和肥胖症)的药物。